David Martinez, PhD., in the lab at the University of North Carolina at Chapel Hill Gillings School of Global Public Health, studies a new universal vaccine that’s effective against a group of coronaviruses.
by University of North Carolina at Chapel Hill
Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous variant.
While no one knows which virus may cause the next outbreak, coronaviruses remain a threat after causing the SARS outbreak in 2003 and the global COVID-19 pandemic.
To prevent a future coronavirus pandemic, UNC-Chapel Hill researchers designed the vaccine to provide protection from the current SARS-CoV-2 coronavirus and a group of coronaviruses known to make the jump from animals to humans.
The findings were published in Science by lead authors David Martinez, a postdoctoral researcher at UNC Gillings School of Global Public Health and a Hanna H. Gray Fellow at the Howard Hughes Medical Institute, and Ralph Baric, an epidemiologist at UNC Gillings School of Global Public Health and professor of immunology and microbiology at the UNC School of Medicine, whose research has sparked new therapies to fight emerging infectious diseases.Continue reading… “Universal vaccine targets coronaviruses to prevent future pandemics”